AIC
SUPN icon

Aurora Investment Counsel’s Supernus Pharmaceuticals SUPN Stock Holding History

Aurora Investment Counsel’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-41,668
Closed -$1.21M – 130
2022
Q2 		$1.21M Hold
41,668
– – 0.87% 47
2022
Q1 		$1.35M Hold
41,668
– – 0.86% 57
2021
Q4 		$1.22M Hold
41,668
– – 0.72% 79
2021
Q3 		$1.11M Sell
41,668
-490
-1% -$13.2K 0.77% 70
2021
Q2 		$1.3M Sell
42,158
-67
-0.2% -$2.05K 0.91% 52
2021
Q1 		$1.1M Buy
+42,225
New +$1.18M 0.81% 68

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aurora Investment Counsel's SUPN Position: Q3 2022 in Review

Aurora Investment Counsel sold out of Supernus Pharmaceuticals (SUPN) in Q3 2022, closing a stake of 41,668 shares — an estimated $1.21M sold.

Aurora Investment Counsel first reported a position in SUPN in Q1 2021 and held it in 6 quarters. The position peaked at $1.35M in Q1 2022. 244 funds tracked by Wall St. Rank hold SUPN as of Q3 2022.

  • Aurora Investment Counsel reported no remaining Supernus Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Aurora Investment Counsel sold 41,668 Supernus Pharmaceuticals shares in Q3 2022, an estimated $1.21M.
  • Aurora Investment Counsel first reported a position in Supernus Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • Aurora Investment Counsel's Supernus Pharmaceuticals position peaked at $1.35M in Q1 2022.
  • 244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2022.

Based on Aurora Investment Counsel's 13F filing for Q3 2022, filed 23 Nov 2022.